Oncolytics Biotech (ONCY) Tops Q4 EPS by 10c

Oncolytics Biotech (NASDAQ: ONCY) reported Q4 EPS of ($0.05), $0.10 better than the analyst estimate of ($0.15).

For earnings history and earnings-related data on Oncolytics Biotech (ONCY) click here.

You May Also Be Interested In

• Trump discloses over $1.4 billion in crypto income in 2025 filing
• Humanoid robot component stocks surge on supply-chain optimism
• Sony to end PlayStation disc production in January 2028